Skip To Main Content
Astra Zeneca Limited on Muck Rack

Astra Zeneca Limited

As seen in: Benzinga, The Lancet, RXLIST®
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work. Claim your profile

Get in touch with Astra Zeneca

Contact Astra Zeneca, search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack

Actions

Share this page

Is this you?

As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile

Articles

Impact of COVID-19 on immunocompromised populations during the Omicron era: insights from the observational population-based INFORM study

|
By Rachael Evans, Sabada Dube, Astra Zeneca Limited, Eastbrook House
| The Lancet Verified
Summary Immunocompromised individuals are not optimally protected by COVID-19 vaccines and potentially require additional preventive interventions to mitigate the risk of severe COVID-19. We aimed to characterise and describe the risk of severe COVID-19 across immunocompromised groups as the pandemic began to transition to an endemic phase.
Open in Who Shared Issue with article?

IMFINZI- durvalumab injection, solution

|
By Astra Zeneca Limited
| nlm.nih.gov
HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use IMFINZI safely and effectively. See full prescribing information for IMFINZI.
Open in Who Shared Issue with article?

Initial Statement of Beneficial Ownership: (Form3) (Amended) (0000899243-19-025368)

|
By Astra Zeneca Limited
| Benzinga
SEC Form 3 FORM 3 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940 OMB APPROVAL OMB Number: 3235-0104 Estimated average burden hours per response: 0.5 1. Name and Address of Reporting Person* 1 FRANCIS CRICK AVENUE CAMBRIDGE BIOMEDICAL CAMPUS (Street) 2.
Open in Who Shared Issue with article?
See all 4 articles